CD274 and cancer: Extensive evidence shows that cancer cells tend to inactivate IFN signaling via immunoediting.94,95 Overexpression of PD-L1 also correlates with tumor progression, possibly by enhancing survival and proliferation pathways in addition to neutralization of the IFN signaling pathway.